ClinicalTrials.Veeva

Menu

Cardiovascular Patients With no Standard Modifiable Risk Factors (SMuRF-less-ME1)

J

Jordan Collaborating Cardiology Group

Status

Completed

Conditions

Cardiovascular Risk Factors

Treatments

Other: Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patients

Study type

Observational

Funder types

Other

Identifiers

NCT06199869
CVA2024.SMuRFless1

Details and patient eligibility

About

A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.

Full description

Atherosclerotic coronary artery disease (ASCAD) claims millions of lives annually on a global level and is the leading cause of death in the Middle East. There are four standard modifiable cardiovascular risk factors (SMuRFs): hypertension, type 2 diabetes mellitus, dyslipidemia, and smoking. These are very common in the Middle East and are crucial to be screened for and addressed in an affective manner.

However, an increasing proportion of patients with ASCVD have none of these individual factors (SMuRF-less). Globally, this proportion comprises 11.6% of individuals with stable coronary disease and heart attack. No prior study has addressed the issue of the prevalence of SMuRF-less patients among the whole population of individuals with ASCVD in the Middle East.

Enrollment

5,540 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A diagnosis of atherosclerotic cardiovascular disease (ASCVD).
  • Ability to fill the clinical form that evaluates the presence or absence of cardiovascular risk factors including the 4 SMuRFs.

Exclusion criteria

  • Atherosclerotic cardiovascular disease diagnosed before the age of 18 years.
  • Inability to give detailed history of prespecified risk factors.

Trial contacts and locations

2

Loading...

Central trial contact

Ali Al-Halabi, MD; Ayman Hammoudeh, MD, FACC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems